Developer docs
API playgroundTry for free, no card

Search company profiles

Jolt Health

Full company profile

uuid0005lwh

Namestring
Jolt Health
Legal namestring
Jolt Health Inc.
Websiteurl
love-pharma.com
Company typeenum
Private
Founded yearint
2021
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersVancouver, Canada
HQ citystring
Vancouver
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
sexual wellness therapeutics, mental wellness products, pharmaceutical licensing, novel therapeutics development, health biotech products
Industry3 codes
1Medical Wellness & Longevity (Health Screening, Biohacking, Anti-aging Programs)
CodeTHAJAHAIPrimaryYes
2Mindfulness & Mental Wellbeing Experiences (Stress Management, Sleep Retreats, Coaching)
CodeTHAJAHAHPrimaryNo
3Healthcare & Wellness Personalization
CodeHDAAAGAIPrimaryNo
NAICS code2 codes
  • Offices of Physicians, Mental Health Specialists621112
  • Outpatient Mental Health and Substance Abuse Centers621420
SIC code3 codes
  • Services-Misc Health & Allied Services, Nec8090
  • Electromedical & Electrotherapeutic Apparatus3845
  • Services-Health Services8000
Product category
Pharmaceutical Therapeutics
Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Jolt Health Inc. is a specialized health and wellness company that holds rights to 7 novel therapeutic products focused on sexual and mental wellness. The company licenses and commercializes these therapeutic and pharmaceutical products across Europe, the UK, and North America, operating as a life sciences organization spanning healthcare, biotechnology, and artificial intelligence.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Jolt Health Inc. is a life sciences organization focused on healthcare, biotechnology, and artificial intelligence. The company holds licensing rights for therapeutic and pharmaceutical products across Europe, the UK, and North America. However, no specific named products, modules, or distinct brand offerings are identified in the available source data.

Product and service1 record
1Novel Therapeutic Products Portfolio (Sexual & Mental Wellness)
CategoryTherapeutic Pharmaceuticals
Description

A portfolio of 7 novel therapeutic products addressing sexual and mental wellness indications, licensed for development and commercialization across multiple major regulatory jurisdictions for life sciences and pharmaceutical partners.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

MindMed is a clinical-stage mental health therapeutics company developing psychedelic-inspired treatments. Like Jolt Health, it pursues novel mental-wellness therapeutics, is publicly listed on a North American exchange, and operates across multiple jurisdictions.

TypeDirect peer
Description

atai is a clinical-stage biopharmaceutical company developing mental health treatments, with multi-region reach and a portfolio approach. Its pipeline model and geographic breadth mirror Jolt Health's licensing-based strategy in mental wellness.

TypeDirect peer
Description

Cybin is a clinical-stage mental wellness therapeutics company pursuing psychedelic-based treatments. It is publicly listed in Canada, operates across multiple regulated markets, and shares Jolt Health's small-cap mental wellness therapeutic focus.

TypeDirect peer
Description

Compass Pathways is a mental health care company developing psilocybin therapy for treatment-resistant depression. Its novel therapeutic approach to mental wellness and multi-jurisdictional clinical operations parallel Jolt Health's positioning.

TypeDirect peer
Description

Numinus is a Canadian mental wellness company offering both therapeutic product development and clinic-based services. Like Jolt Health, it is a small-cap Canadian public company operating at the intersection of mental wellness therapeutics and broader health services.

TypeDirect peer
Description

Bright Minds is a clinical-stage biotech developing novel CNS therapeutics for mental health conditions. Its small-cap public status and pipeline-of-therapeutics model make it a comparable early-stage peer in the mental wellness drug development space.

TypeDirect peer
Description

GH Research is a clinical-stage biopharmaceutical company developing mental health therapeutics. Its novel-mechanism, multi-jurisdictional development approach mirrors Jolt Health's mental wellness therapeutic ambitions.

TypeBroad incumbent
Description

Hims & Hers is a major consumer health platform addressing both sexual wellness and mental health. While larger and more established, it is a comparable competitor for the end-customer demand that Jolt Health's therapeutic products would ultimately serve.

9Ro
TypeBroad incumbent
Description

Ro is a direct-to-patient healthcare company operating in men's sexual wellness, mental health, and other verticals. It shares Jolt Health's sexual/mental wellness consumer focus, though at significantly larger scale and with owned distribution infrastructure.

TypeBroad incumbent
Description

Cerebral is a mental health platform providing online therapy and medication management. It competes for the same mental wellness demand as Jolt Health's therapeutic pipeline, though with a services-plus-pharmacy model rather than a licensing-based pharma model.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat1 record

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Jolt Health

Pharmaceutical Therapeuticslove-pharma.com

Jolt Health firmographics

Firmographics
Name
Jolt Health
Legal name
Jolt Health Inc.
Website
https://love-pharma.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Jolt Health industry classification

Industry
Product category
Pharmaceutical Therapeutics
NAICS
Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (621420)
SIC
Services-Misc Health & Allied Services, Nec (8090), Electromedical & Electrotherapeutic Apparatus (3845), Services-Health Services (8000)
akta.pro primary industry
Medical Wellness & Longevity (Health Screening, Biohacking, Anti-aging Programs) (THAJAHAI)
akta.pro secondary industries
Mindfulness & Mental Wellbeing Experiences (Stress Management, Sleep Retreats, Coaching) (THAJAHAH), Healthcare & Wellness Personalization (HDAAAGAI)

Keywords

  • Sexual wellness therapeutics
  • Mental wellness products
  • Pharmaceutical licensing
  • Novel therapeutics development
  • Health biotech products

Where Jolt Health is headquartered

Location

Headquarters

HQ city
Vancouver
HQ country
Canada
HQ region
North America

Markets served

Jolt Health business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Jolt Health product offering

Product offering

Core offering

Jolt Health Inc. is a specialized health and wellness company that holds rights to 7 novel therapeutic products focused on sexual and mental wellness. The company licenses and commercializes these therapeutic and pharmaceutical products across Europe, the UK, and North America, operating as a life sciences organization spanning healthcare, biotechnology, and artificial intelligence.

Product overview

Jolt Health Inc. is a life sciences organization focused on healthcare, biotechnology, and artificial intelligence. The company holds licensing rights for therapeutic and pharmaceutical products across Europe, the UK, and North America. However, no specific named products, modules, or distinct brand offerings are identified in the available source data.

Differentiator

Problem solved

Functional benefit

Products and services

  • Novel Therapeutic Products Portfolio (Sexual & Mental Wellness) A portfolio of 7 novel therapeutic products addressing sexual and mental wellness indications, licensed for development and commercialization across multiple major regulatory jurisdictions for life sciences and pharmaceutical partners.

Companies that use Jolt Health

Customer profile

Segments1 record

Ideal customer profiles1 record

Jolt Health technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Jolt Health partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Jolt Health competitors and assessment

Company assessment

Direct peers

  • MindMed: MindMed is a clinical-stage mental health therapeutics company developing psychedelic-inspired treatments. Like Jolt Health, it pursues novel mental-wellness therapeutics, is publicly listed on a North American exchange, and operates across multiple jurisdictions.
  • atai Life Sciences: atai is a clinical-stage biopharmaceutical company developing mental health treatments, with multi-region reach and a portfolio approach. Its pipeline model and geographic breadth mirror Jolt Health's licensing-based strategy in mental wellness.
  • Cybin: Cybin is a clinical-stage mental wellness therapeutics company pursuing psychedelic-based treatments. It is publicly listed in Canada, operates across multiple regulated markets, and shares Jolt Health's small-cap mental wellness therapeutic focus.
  • Compass Pathways: Compass Pathways is a mental health care company developing psilocybin therapy for treatment-resistant depression. Its novel therapeutic approach to mental wellness and multi-jurisdictional clinical operations parallel Jolt Health's positioning.
  • Numinus Wellness: Numinus is a Canadian mental wellness company offering both therapeutic product development and clinic-based services. Like Jolt Health, it is a small-cap Canadian public company operating at the intersection of mental wellness therapeutics and broader health services.
  • Bright Minds Biosciences: Bright Minds is a clinical-stage biotech developing novel CNS therapeutics for mental health conditions. Its small-cap public status and pipeline-of-therapeutics model make it a comparable early-stage peer in the mental wellness drug development space.
  • GH Research: GH Research is a clinical-stage biopharmaceutical company developing mental health therapeutics. Its novel-mechanism, multi-jurisdictional development approach mirrors Jolt Health's mental wellness therapeutic ambitions.

Broad incumbents

  • Hims & Hers Health: Hims & Hers is a major consumer health platform addressing both sexual wellness and mental health. While larger and more established, it is a comparable competitor for the end-customer demand that Jolt Health's therapeutic products would ultimately serve.
  • Ro: Ro is a direct-to-patient healthcare company operating in men's sexual wellness, mental health, and other verticals. It shares Jolt Health's sexual/mental wellness consumer focus, though at significantly larger scale and with owned distribution infrastructure.
  • Cerebral: Cerebral is a mental health platform providing online therapy and medication management. It competes for the same mental wellness demand as Jolt Health's therapeutic pipeline, though with a services-plus-pharmacy model rather than a licensing-based pharma model.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat1 record

Key risks6 records

Key highlights5 records

Customer concentration

Jolt Health social profiles

Digital presence

Jolt Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Jolt Health leadership team

Management profile

Number of profiles

Profiles1 record

Jolt Health funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Jolt Health M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jolt Health

What does Jolt Health do?

Jolt Health Inc. is a specialized health and wellness company that holds rights to 7 novel therapeutic products focused on sexual and mental wellness. The company licenses and commercializes these therapeutic and pharmaceutical products across Europe, the UK, and North America, operating as a life sciences organization spanning healthcare, biotechnology, and artificial intelligence.

Is Jolt Health a public or private company?

Jolt Health is a private company. It is classified as public and is currently operating.

When was Jolt Health founded?

Jolt Health was founded in 2021. It employs 11 to 50 people.

Where is Jolt Health based?

Jolt Health is headquartered in Vancouver, Canada, in the North America region.

Who are Jolt Health's main competitors?

Direct peers on record are MindMed, atai Life Sciences, Cybin, Compass Pathways, Numinus Wellness, Bright Minds Biosciences and GH Research. Broad incumbents are Hims & Hers Health, Ro and Cerebral.

Does Jolt Health have an API?

No public API is recorded for Jolt Health.

What industry is Jolt Health in?

Jolt Health's product category is Pharmaceutical Therapeutics. Its primary akta.pro industry code is THAJAHAI, Medical Wellness & Longevity (Health Screening, Biohacking, Anti-aging Programs), with a secondary code of THAJAHAH, Mindfulness & Mental Wellbeing Experiences (Stress Management, Sleep Retreats, Coaching). Its NAICS code is 621112 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooJolt Health Inc. Announces FinancingJolt Health Inc. announced a non-brokered private placement of up to $500,000 to issue up to 583,333,333 units at a price of $0.006 per unit. The financing aims to support general working capital, with certain insiders expected to participate. The company focuses on healthcare, biotechnology, and artificial intelligence, holding exclusive licenses for innovative products in Europe, the UK, and North America.PharmiWeb.comJolt Health Inc. Announces FinancingJolt Health Inc. announced a non-brokered private placement of up to $500,000, issuing approximately 583 million units at $0.006 per unit. The company intends to use the net proceeds for general working capital, with anticipated participation from insiders. This financing relies on specific regulatory exemptions regarding valuation and minority approval.GlobeNewswireJOLT HEALTH INC. ANNOUNCES FINANCINGJolt Health Inc. announced a non-brokered private placement of up to $380,000, issuing up to 76 million units at $0.005 each. Each unit includes a common share and a warrant to buy another share at $0.05, with proceeds for general working capital.GlobeNewswireJOLT HEALTH INC. ANNOUNCES CLOSINGJolt Health Inc. closed its private placement on July 10, 2023, issuing 6,984,266 units for gross proceeds of $100,125. Each unit includes a common share and a warrant exercisable at $0.05, with an insider subscribing for 1,400,000 units.GlobeNewswireJOLT HEALTH INC. ANNOUNCES CLOSINGJolt Health Inc. announced the closure of its private placement on July 10, 2023, raising $100,125 by issuing 6,984,266 units at $0.0143 each. Each unit consists of one common share and one common share warrant, with insider participation amounting to 1,400,000 units.GlobeNewswireJOLT HEALTH INC. ANNOUNCES CLOSINGJolt Health Inc. announced it will close its non-brokered private placement on July 15, 2023, issuing 6,984,266 units for gross proceeds of $100,125. Each unit includes a common share and a warrant to buy another share at $0.05, with a finders fee of $1,125.25 and 87,500 broker warrants.GlobeNewswireJOLT HEALTH INC. ANNOUNCES CLOSINGJolt Health Inc. announced the closing of its previously announced non-brokered private placement financing scheduled for July 15, 2023. The company will issue 6,984,266 units for gross proceeds of $100,125 at a price of $0.0143 per unit.GlobeNewswireJOLT HEALTH INC. ANNOUNCES FINANCINGJolt Health Inc. announced a non-brokered private placement of up to $400,000, issuing up to 27,972,028 units at $0.0143 each. Proceeds will fund general working capital and review possible acquisitions. The company may pay finders fees of 8% cash and 8% in warrants.GlobeNewswireJOLT HEALTH INC. ANNOUNCES NEW CEO AND DIRECTOR TO LEAD BIOTECHNOLOGY, HEALTHCARE AND AI INITIATIVESGerald Tritt has been appointed CEO and Director of Jolt Health, effective immediately, succeeding Zachary Stadnyk. Tritt brings experience from restaurant chains and biotech consulting, while Stadnyk will remain an advisor on corporate finance and acquisitions.GlobeNewswireJOLT Health Inc. Announces Issuance of Common Shares in Satisfaction of Interest Payments to Promissory Note Holders and Interest Payment to Convertible Debenture HolderJolt Health Inc. issued 13,765,763 common shares at $0.015 each to satisfy $195,000 in interest on a convertible debenture, and 6,116,913 shares at $0.15 each for 5% interest on promissory notes. The shares are subject to a four-month hold period and CSE approval.